| Metrion Biosciences Ltd (“Metrion”), the specialist preclinical contract research organization (CRO) and a leader in ion channel screening, today announced the appointment of Dr Chris Mathes, MBA, as |
Debate... noitisoppO gnortS dimA sihsotaNexo... 3202 yraunaJ fo sesaeler eht ,Why... rehgih gnimrots era serahs laoAll... evirD tseroF ta htuoS 77 etatsLindsay... emehcs otpyrc revo segrahc SUSNGPL... arazaH ni tfeht sag tsniaga evThis... recnaC lanretaM neddiH laeveRRory... sthgieh wen sehcaer snoitarbelUN... lortnoc rof thgif slareneg gniMKR... ’lian dna htoot thguoF‘ :swen